MML Investors Services’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$599K Sell
7,659
-6,220
-45% -$486K ﹤0.01% 1975
2025
Q1
$1.01M Buy
13,879
+742
+6% +$53.8K ﹤0.01% 1568
2024
Q4
$973K Sell
13,137
-20,978
-61% -$1.55M ﹤0.01% 1524
2024
Q3
$2.25M Sell
34,115
-64,525
-65% -$4.26M 0.01% 1031
2024
Q2
$9.11M Sell
98,640
-9,449
-9% -$873K 0.04% 421
2024
Q1
$10.3M Sell
108,089
-14,830
-12% -$1.42M 0.04% 400
2023
Q4
$9.37M Buy
122,919
+27,488
+29% +$2.1M 0.04% 394
2023
Q3
$6.61M Buy
95,431
+5,271
+6% +$365K 0.04% 441
2023
Q2
$8.51M Buy
+90,160
New +$8.51M 0.05% 369
2023
Q1
Sell
-93,345
Closed -$6.96M 2138
2022
Q4
$6.96M Buy
93,345
+4,333
+5% +$323K 0.05% 391
2022
Q3
$7.36M Buy
89,012
+82
+0.1% +$6.78K 0.06% 331
2022
Q2
$8.46M Buy
88,930
+8,788
+11% +$836K 0.06% 293
2022
Q1
$9.43M Buy
80,142
+5,264
+7% +$620K 0.07% 288
2021
Q4
$9.7M Buy
74,878
+4,935
+7% +$639K 0.07% 284
2021
Q3
$7.92M Buy
69,943
+5,663
+9% +$641K 0.06% 309
2021
Q2
$6.66M Buy
64,280
+6,712
+12% +$695K 0.06% 330
2021
Q1
$4.82M Buy
57,568
+10,775
+23% +$901K 0.05% 380
2020
Q4
$4.27M Buy
46,793
+8,831
+23% +$806K 0.05% 352
2020
Q3
$3.03M Buy
37,962
+6,705
+21% +$535K 0.04% 387
2020
Q2
$2.16M Buy
31,257
+12,819
+70% +$886K 0.03% 474
2020
Q1
$1.16M Buy
18,438
+1,863
+11% +$117K 0.02% 583
2019
Q4
$1.29M Buy
16,575
+2,676
+19% +$208K 0.02% 624
2019
Q3
$1.02M Sell
13,899
-1,338
-9% -$98.1K 0.02% 658
2019
Q2
$938K Buy
15,237
+927
+6% +$57.1K 0.01% 741
2019
Q1
$913K Sell
14,310
-936
-6% -$59.7K 0.01% 745
2018
Q4
$778K Sell
15,246
-11,520
-43% -$588K 0.01% 715
2018
Q3
$1.55M Buy
26,766
+3,036
+13% +$176K 0.03% 530
2018
Q2
$1.15M Sell
23,730
-1,500
-6% -$72.8K 0.03% 519
2018
Q1
$1.17M Sell
25,230
-1,803
-7% -$83.8K 0.02% 501
2017
Q4
$1.02M Sell
27,033
-5,271
-16% -$198K 0.02% 544
2017
Q3
$1.18M Buy
32,304
+3,837
+13% +$140K 0.02% 458
2017
Q2
$1.12M Sell
28,467
-156
-0.5% -$6.15K 0.02% 471
2017
Q1
$898K Buy
+28,623
New +$898K 0.02% 301